The Journal of
Clinical Psychiatry

Posttraumatic Stress Disorder

Letter to the Editor June 18, 2002

Reply to Letter to the Editor "Design and Interpretability of Findings in a Family Study to Investigate Posttraumatic Stress Disorder"

Lisa C. Dierker ; Kathleen R. Merikangas

J Clin Psychiatry 2002;63(6):538

Article Abstract

Letter to the Editor

Sir: Droege’s critique of the rigors of the design and interpretability of findings in our article is unfounded.

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 86 • 2025 • Number 1

Read the Current Issue

Brief Report

Sex Differences in PTSD among US Military Veterans

Commentary

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Clinical and Practical Psychopharmacology

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Commentary

Evolving Care and Research Priorities in ADHD

Original Research

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Systematic Review

Efficacy and Safety of Memantine for Children and Adults with ADHD

View current Issue

Letter to the Editor

TMS for Veterans With Comorbid Depression and PTSD

March 30, 2021

In this letter, Dr Hernandez and colleagues reply to a letter from Brigido et al that comments on their recent article on the impact of comorbid posttraumatic stress disorder...

Michael J. Hernandez , Tea Reljic , Kimberly Van Trees , et al

Letter to the Editor

PTSD May Impact Depression Response and Remission to TMS

March 30, 2021

This letter to the editor builds on the findings of a recent article by Hernandez and colleagues on the impact of comorbid posttraumatic stress disorder on outcomes of treatment...

Sydney Brigido , Melanie Bozzay , Noah S. Philip

Letter to the Editor

Adrenergic Mediation of Dissociative Symptoms in Posttraumatic Stress Disorder

April 27, 2016

Matthew J. Friedman

Reply to Letter to the Editor "Design and Interpretability of Findings in a Family Study to Investigate Posttraumatic Stress Disorder"

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

ELSEWHERE:

FOLLOW US:

Reply to Letter to the Editor "Design and Interpretability of Findings in a Family Study to Investigate Posttraumatic Stress Disorder"

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

Related Articles

TMS for Veterans With Comorbid Depression and PTSD

PTSD May Impact Depression Response and Remission to TMS

Adrenergic Mediation of Dissociative Symptoms in Posttraumatic Stress Disorder

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles